Brooke DeFosse
PharmD, BCPS, CPE, Clinical Product Specialist
axialHealthcare
Brooke DeFosse is a clinical product specialist with axialHealthcare, a national pain management solutions company based in Nashville. As an axial clinician, she serves as a clinical resource for internal multifunctional teams and applies her pharmaceutical and substance abuse knowledge to analytics methodology and product development. DeFosse received her Bachelor of Science degree from Middle Tennessee State University in 2011 and her PharmD from the University of Tennessee College of Pharmacy in 2015. After graduation, she completed a managed care residency with the Tennessee Department of Mental Health and Substance Abuse Services and the University of Tennessee.
Using Clinical Expertise and the Latest Evidence to Build Effective Solutions for Opioid Use Disorder Treatment and to Reduce Associated Costs - Hosted by axialHealthcare
PharmD, BCPS, CPE, Clinical Product Specialist
axialHealthcare
Brooke DeFosse is a clinical product specialist with axialHealthcare, a national pain management solutions company based in Nashville. As an axial clinician, she serves as a clinical resource for internal multifunctional teams and applies her pharmaceutical and substance abuse knowledge to analytics methodology and product development. DeFosse received her Bachelor of Science degree from Middle Tennessee State University in 2011 and her PharmD from the University of Tennessee College of Pharmacy in 2015. After graduation, she completed a managed care residency with the Tennessee Department of Mental Health and Substance Abuse Services and the University of Tennessee.
Using Clinical Expertise and the Latest Evidence to Build Effective Solutions for Opioid Use Disorder Treatment and to Reduce Associated Costs - Hosted by axialHealthcare
Greg Delaney
Outreach Coordinator
Woodhaven Ohio
Pastor Greg Delaney who serves as the Outreach Coordinator at Woodhaven, which is a treatment center known as “a safe place to recover.” Delaney is a frequent Faith Collaborator with/for the Ohio Attorney General Mike DeWine's Statewide Outreach on Substance Use, as well as Attorney General Patrick Morrisey of West Virginia’s Combating Addiction with Grace initiative. Delaney has been instrumental in a number of initiatives, such as The CHAMPIONS NETWORK, a coordinated and collaborative network of qualified individuals, community-based services, ministries and churches ministering to the addicted in our local communities, and an ongoing weekday BLOG called “Opportunities for Hope,” which offers messages of encouragement and recovery to its readers and subscribers. He also hosts a weekly radio show of the same name broadcast on 90.9 in Lancaster, Ohio.
Hope In Action: Partnering with Faith-Based Communities to Address the Opioid Epidemic
Outreach Coordinator
Woodhaven Ohio
Pastor Greg Delaney who serves as the Outreach Coordinator at Woodhaven, which is a treatment center known as “a safe place to recover.” Delaney is a frequent Faith Collaborator with/for the Ohio Attorney General Mike DeWine's Statewide Outreach on Substance Use, as well as Attorney General Patrick Morrisey of West Virginia’s Combating Addiction with Grace initiative. Delaney has been instrumental in a number of initiatives, such as The CHAMPIONS NETWORK, a coordinated and collaborative network of qualified individuals, community-based services, ministries and churches ministering to the addicted in our local communities, and an ongoing weekday BLOG called “Opportunities for Hope,” which offers messages of encouragement and recovery to its readers and subscribers. He also hosts a weekly radio show of the same name broadcast on 90.9 in Lancaster, Ohio.
Hope In Action: Partnering with Faith-Based Communities to Address the Opioid Epidemic
Brian DeLeonardo
JD, State's Attorney
Carroll County, Maryland
State’s Attorney Brian DeLeonardo has served since 2014 as the chief law enforcement officer for Carroll County, Maryland, and oversees an office of 43 prosecutors, investigators and support staff. He previously served as an Assistant Attorney General for Maryland, and as the managing partner in a law firm where he represented hundreds of clients facing criminal charges as a result of their battle with drug addiction. He served as an Adjunct Law Professor at the University Of Baltimore School Of Law and as instructor for both state and federal law enforcement agencies for over 15 years, including the Maryland State Police, Department of Homeland Security, Federal Bureau of Investigations, and Bureau of Alcohol, Tobacco, Firearms and Explosives. He was appointed in 2016 by Maryland Gov. Larry Hogan to serve on Maryland’s Criminal Sentencing Commission. He participated in the Law Enforcement Subcommittee for the Maryland Governor’s Heroin Task Force, which was formed to discuss innovative ways to address the rise in opioid overdoses. DeLeonardo is the elected Vice President of the Maryland State’s Attorney’s Association and is the head of the Legislation Committee for the association.
Stamp Out Heroin: One County's Three-Pronged Approach
JD, State's Attorney
Carroll County, Maryland
State’s Attorney Brian DeLeonardo has served since 2014 as the chief law enforcement officer for Carroll County, Maryland, and oversees an office of 43 prosecutors, investigators and support staff. He previously served as an Assistant Attorney General for Maryland, and as the managing partner in a law firm where he represented hundreds of clients facing criminal charges as a result of their battle with drug addiction. He served as an Adjunct Law Professor at the University Of Baltimore School Of Law and as instructor for both state and federal law enforcement agencies for over 15 years, including the Maryland State Police, Department of Homeland Security, Federal Bureau of Investigations, and Bureau of Alcohol, Tobacco, Firearms and Explosives. He was appointed in 2016 by Maryland Gov. Larry Hogan to serve on Maryland’s Criminal Sentencing Commission. He participated in the Law Enforcement Subcommittee for the Maryland Governor’s Heroin Task Force, which was formed to discuss innovative ways to address the rise in opioid overdoses. DeLeonardo is the elected Vice President of the Maryland State’s Attorney’s Association and is the head of the Legislation Committee for the association.
Stamp Out Heroin: One County's Three-Pronged Approach
Kurt DeVine
MD, Family Physician
Family Medical Center, CHI St Gabriel's
Dr. Kurt Devine has been a full spectrum family medicine physician for more than 26 years. As a practicing physician in rural Minnesota, he has faced many unique challenges caring for patients in the primary care setting amid evolving care delivery models demanded forward thinking and creative strategies for change. As opioid use and its attributing issues became increasingly apparent, he became more engaged and involved with the local community task force assembled to address concerns of opioid use and dependency within the county. He quickly discovered the importance of guiding change with a strong provider championship and building impactful community partnerships. His leadership has enabled grant funding to be put to practical use and demonstrate positive outcomes from both the financial and patient care perspectives. Over the last year he has provided medication assisted treatment. It is his exemplary leadership, Devine created a culture shift within his own practice and other practices throughout the state. The program model he created has shown significant impact on opioid prescribing, as well as treatment of patients and will be reproduced in other communities with the help of recent legislative funding.
A Rural Primary Care Clinic's Successful Response to the Opioid Epidemic
MD, Family Physician
Family Medical Center, CHI St Gabriel's
Dr. Kurt Devine has been a full spectrum family medicine physician for more than 26 years. As a practicing physician in rural Minnesota, he has faced many unique challenges caring for patients in the primary care setting amid evolving care delivery models demanded forward thinking and creative strategies for change. As opioid use and its attributing issues became increasingly apparent, he became more engaged and involved with the local community task force assembled to address concerns of opioid use and dependency within the county. He quickly discovered the importance of guiding change with a strong provider championship and building impactful community partnerships. His leadership has enabled grant funding to be put to practical use and demonstrate positive outcomes from both the financial and patient care perspectives. Over the last year he has provided medication assisted treatment. It is his exemplary leadership, Devine created a culture shift within his own practice and other practices throughout the state. The program model he created has shown significant impact on opioid prescribing, as well as treatment of patients and will be reproduced in other communities with the help of recent legislative funding.
A Rural Primary Care Clinic's Successful Response to the Opioid Epidemic
Bethany DiPaula
PharmD, BCPP, Associate Professor, School of Pharmacy
University of Maryland - Baltimore
Bethany A. DiPaula, PharmD, BCPP, is an Associate Professor at the University of Maryland School of Pharmacy, Baltimore, Director of Pharmacy at Springfield Hospital Center, and Clinical Pharmacist at Helping Up Mission. DiPaula completed her Doctor in Pharmacy and psychiatric residency training at the University Of Maryland School Of Pharmacy, Baltimore. She became a Board Certified Psychiatric Pharmacist in 1997. DiPaula has been active in shaping state collaborative drug therapy management legislation and in developing physician-pharmacist collaborative practices. She currently practices collaboratively providing medication management services for psychiatric and opioid use disorder patients at Helping Up Mission. She previously created a collaborative buprenorphine/naloxone-maintenance program at a federally funded community health clinic and a local health department. She received state approval for her physician-pharmacist opioid use disorder and psychiatric disorders drug therapy management protocols. DiPaula has worked on a state committee, which legislatively advocated for expanded access to naloxone through greater pharmacist involvement. She has served as an instructor and supervisor for Maryland’s opioid overdose response program curriculum at a local health department. DiPaula has mentored addicted pharmacists while volunteering with the Pharmacist Education and Assistance Committee.
Interprofessional Excellence: Integrating Pharmacists into the MAT Team
PharmD, BCPP, Associate Professor, School of Pharmacy
University of Maryland - Baltimore
Bethany A. DiPaula, PharmD, BCPP, is an Associate Professor at the University of Maryland School of Pharmacy, Baltimore, Director of Pharmacy at Springfield Hospital Center, and Clinical Pharmacist at Helping Up Mission. DiPaula completed her Doctor in Pharmacy and psychiatric residency training at the University Of Maryland School Of Pharmacy, Baltimore. She became a Board Certified Psychiatric Pharmacist in 1997. DiPaula has been active in shaping state collaborative drug therapy management legislation and in developing physician-pharmacist collaborative practices. She currently practices collaboratively providing medication management services for psychiatric and opioid use disorder patients at Helping Up Mission. She previously created a collaborative buprenorphine/naloxone-maintenance program at a federally funded community health clinic and a local health department. She received state approval for her physician-pharmacist opioid use disorder and psychiatric disorders drug therapy management protocols. DiPaula has worked on a state committee, which legislatively advocated for expanded access to naloxone through greater pharmacist involvement. She has served as an instructor and supervisor for Maryland’s opioid overdose response program curriculum at a local health department. DiPaula has mentored addicted pharmacists while volunteering with the Pharmacist Education and Assistance Committee.
Interprofessional Excellence: Integrating Pharmacists into the MAT Team
John Dombrowski
MD, FASA, DABAM, Chief Executive Officer
Washington Pain Center
Dr. John Dombrowski has 25 years of experience in anesthesiology and pain medicine. With the rise of addiction in the United States, he became board certified in addiction medicine to treat these patients. He is a frequent lecturer across the country to discuss techniques that anesthesiologists can use to limit the amount of opiates provided patients. Also, he is frequently on national television, such as FOXNews, Good Morning America and Today.
Treating Chronic Pain in a Non-Opiate-Based Format
MD, FASA, DABAM, Chief Executive Officer
Washington Pain Center
Dr. John Dombrowski has 25 years of experience in anesthesiology and pain medicine. With the rise of addiction in the United States, he became board certified in addiction medicine to treat these patients. He is a frequent lecturer across the country to discuss techniques that anesthesiologists can use to limit the amount of opiates provided patients. Also, he is frequently on national television, such as FOXNews, Good Morning America and Today.
Treating Chronic Pain in a Non-Opiate-Based Format
KariLynn Dowling
PharmD, Community Pharmacy Practice Research Fellow
Gatton College of Pharmacy, East Tennessee State University
KariLynn Dowling, PharmD, is a Community Pharmacy Practice Research Fellow and adjunct faculty member at East Tennessee State University (ETSU) Gatton College of Pharmacy. She is a 2014 graduate of the University of Montana Skaggs School of Pharmacy. She completed residency training at Penobscot Community Health Care in Bangor, Maine, as a member of the 2014-15 PGY1 Community Pharmacy and 2015-16 PGY2 Health-Systems Pharmacy Administration residency classes. As a resident, Dowling focused on controlled substance stewardship and program implementation for intranasal naloxone and medication assisted therapy initiatives. Her career interests include Rx drug abuse research, addiction treatment, and academia. Dowling is pursuing a Master of Public Health (community health concentration) from ETSU.
Community Pharmacists and Harm Reduction: Evidence and Opportunities
PharmD, Community Pharmacy Practice Research Fellow
Gatton College of Pharmacy, East Tennessee State University
KariLynn Dowling, PharmD, is a Community Pharmacy Practice Research Fellow and adjunct faculty member at East Tennessee State University (ETSU) Gatton College of Pharmacy. She is a 2014 graduate of the University of Montana Skaggs School of Pharmacy. She completed residency training at Penobscot Community Health Care in Bangor, Maine, as a member of the 2014-15 PGY1 Community Pharmacy and 2015-16 PGY2 Health-Systems Pharmacy Administration residency classes. As a resident, Dowling focused on controlled substance stewardship and program implementation for intranasal naloxone and medication assisted therapy initiatives. Her career interests include Rx drug abuse research, addiction treatment, and academia. Dowling is pursuing a Master of Public Health (community health concentration) from ETSU.
Community Pharmacists and Harm Reduction: Evidence and Opportunities
Karen Drexler
MD, National Mental Health Program Director - Substance Use Disorders, VACO
Veterans Health Administration, field-based at the Atlanta VA Medical Center
Dr. Karen Drexler serves as National Mental Health Program Director for Substance Use Disorders in the Office of Mental Health and Suicide Prevention in VA Central Office. She graduated from Duke University School of Medicine and completed her psychiatry residency at Wilford Hall U.S. Air Force Medical Center in San Antonio, Texas. She served four years as a psychiatrist and Medical Director of the Alcohol Rehabilitation Center at Wright-Patterson Air Force Base and on the faculty at Wright State University School of Medicine in Dayton, Ohio. She is an Associate Professor in the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine, where she was Addiction Psychiatry Residency Training Director from 2002 to 2014. Her research interests include clinical trials in addiction treatment and translational research on the neurobiology of addiction. She serves as a member of the Board of Directors of the American Academy of Addiction Psychiatry, and as a member of the Board of Directors of the Community Anti-Drug Coalitions of America. She continues to actively practice addiction psychiatry at the Atlanta VA Medical Center.
VA Best Practices: S.T.O.P. P.A.I.N Initiative and Practice Guidelines
MD, National Mental Health Program Director - Substance Use Disorders, VACO
Veterans Health Administration, field-based at the Atlanta VA Medical Center
Dr. Karen Drexler serves as National Mental Health Program Director for Substance Use Disorders in the Office of Mental Health and Suicide Prevention in VA Central Office. She graduated from Duke University School of Medicine and completed her psychiatry residency at Wilford Hall U.S. Air Force Medical Center in San Antonio, Texas. She served four years as a psychiatrist and Medical Director of the Alcohol Rehabilitation Center at Wright-Patterson Air Force Base and on the faculty at Wright State University School of Medicine in Dayton, Ohio. She is an Associate Professor in the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine, where she was Addiction Psychiatry Residency Training Director from 2002 to 2014. Her research interests include clinical trials in addiction treatment and translational research on the neurobiology of addiction. She serves as a member of the Board of Directors of the American Academy of Addiction Psychiatry, and as a member of the Board of Directors of the Community Anti-Drug Coalitions of America. She continues to actively practice addiction psychiatry at the Atlanta VA Medical Center.
VA Best Practices: S.T.O.P. P.A.I.N Initiative and Practice Guidelines
John J. Dreyzehner
MD, MPH, FACOEM, Commissioner
Tennessee Department of Health, and Member, National Rx Drug Abuse & Heroin Summit Advisory Board
John J. Dreyzehner, MD, MPH, FACOEM, joined Gov. Bill Haslam’s cabinet Sept. 19, 2011, as the 12th Commissioner of the Tennessee Department of Health, having more than 20 years of service in clinical and public health leadership at the federal, state and local levels. He began his medical service in 1989 as a U.S. Air Force flight surgeon. Following honorable discharge as a Major, he spent several years practicing occupational medicine, joining the Virginia Department of Health in 2002. He also concurrently practiced addiction medicine for several years while working on substance abuse prevention in his public health role. Dreyzehner graduated from the University of Illinois at Champaign-Urbana Magna Cum Laude with a Bachelor of Science in psychology. He received his Doctor of Medicine from the University of Illinois at Chicago, and earned his Master of Public Health at the University of Utah, where he also completed his residency in occupational medicine. He and his wife Jana, a child psychiatrist, have two sons. Dreyzehner is a member of the National Rx Drug Abuse & Heroin Summit Advisory Board.
MD, MPH, FACOEM, Commissioner
Tennessee Department of Health, and Member, National Rx Drug Abuse & Heroin Summit Advisory Board
John J. Dreyzehner, MD, MPH, FACOEM, joined Gov. Bill Haslam’s cabinet Sept. 19, 2011, as the 12th Commissioner of the Tennessee Department of Health, having more than 20 years of service in clinical and public health leadership at the federal, state and local levels. He began his medical service in 1989 as a U.S. Air Force flight surgeon. Following honorable discharge as a Major, he spent several years practicing occupational medicine, joining the Virginia Department of Health in 2002. He also concurrently practiced addiction medicine for several years while working on substance abuse prevention in his public health role. Dreyzehner graduated from the University of Illinois at Champaign-Urbana Magna Cum Laude with a Bachelor of Science in psychology. He received his Doctor of Medicine from the University of Illinois at Chicago, and earned his Master of Public Health at the University of Utah, where he also completed his residency in occupational medicine. He and his wife Jana, a child psychiatrist, have two sons. Dreyzehner is a member of the National Rx Drug Abuse & Heroin Summit Advisory Board.
Laura Dunlap
PhD, Senior Director, Behavioral Health Services, Policy and Economics Research
RTI International
Laura J. Dunlap, PhD, is Senior Director of RTI International’s Behavioral Health Services, Policy, and Economics Research Program. She has over 20 years of experience conducting evaluations of substance abuse treatment programs and the systems in which they provide services, including medication assisted treatment for opioid use disorders (OUDs). She currently serves as the Project Director for the Centers for Disease Control and Prevention-funded Evaluation of Medication Assisted Treatment. She recently led the Office of The Assistant Secretary for Planning and Evaluation-funded Telehealth study, which examined use of telehealth for expanding access to treatment of OUDs. She has led numerous research studies in the field of behavioral health on multiple federal contracts and grants, including for the Substance Abuse and Mental Health Services Administration and the National Institutes of Health. Dunlap has published her findings in numerous journals.
Expanding Access to OUD Treatment: The Role of Telehealth
PhD, Senior Director, Behavioral Health Services, Policy and Economics Research
RTI International
Laura J. Dunlap, PhD, is Senior Director of RTI International’s Behavioral Health Services, Policy, and Economics Research Program. She has over 20 years of experience conducting evaluations of substance abuse treatment programs and the systems in which they provide services, including medication assisted treatment for opioid use disorders (OUDs). She currently serves as the Project Director for the Centers for Disease Control and Prevention-funded Evaluation of Medication Assisted Treatment. She recently led the Office of The Assistant Secretary for Planning and Evaluation-funded Telehealth study, which examined use of telehealth for expanding access to treatment of OUDs. She has led numerous research studies in the field of behavioral health on multiple federal contracts and grants, including for the Substance Abuse and Mental Health Services Administration and the National Institutes of Health. Dunlap has published her findings in numerous journals.
Expanding Access to OUD Treatment: The Role of Telehealth
Robert DuPont MD
MD, President
Institute for Behavior and Health, Inc., and Member, National Rx Drug Abuse & Heroin Summit Advisory Board
For over 40 years, Dr. Robert L. DuPont has been a leader in drug abuse prevention and treatment. He was the first Director of the National Institute on Drug Abuse (1973-1978) and the second White House Drug Chief (1973-1977). From 1968-1970, he was Director of Community Services for the District of Columbia Department of Corrections. From 1970-1973, he served as Administrator of the District of Columbia Narcotics Treatment Administration. In 1978, he became the founding President of the Institute for Behavior and Health, Inc. He has been Clinical Professor of Psychiatry at the Georgetown University School of Medicine since 1980. He is a Distinguished Fellow of the American Society of Addiction Medicine and Life Fellow of the American Psychiatric Association. DuPont's signature role throughout his career has been to focus on the public health goal of reducing the use of illegal drugs.
The National Opioid Overdose Epidemic: It’s Not Just Opioids
Long-Term Recovery: The Essential Roles of Families and Addiction Treatment Providers
MD, President
Institute for Behavior and Health, Inc., and Member, National Rx Drug Abuse & Heroin Summit Advisory Board
For over 40 years, Dr. Robert L. DuPont has been a leader in drug abuse prevention and treatment. He was the first Director of the National Institute on Drug Abuse (1973-1978) and the second White House Drug Chief (1973-1977). From 1968-1970, he was Director of Community Services for the District of Columbia Department of Corrections. From 1970-1973, he served as Administrator of the District of Columbia Narcotics Treatment Administration. In 1978, he became the founding President of the Institute for Behavior and Health, Inc. He has been Clinical Professor of Psychiatry at the Georgetown University School of Medicine since 1980. He is a Distinguished Fellow of the American Society of Addiction Medicine and Life Fellow of the American Psychiatric Association. DuPont's signature role throughout his career has been to focus on the public health goal of reducing the use of illegal drugs.
The National Opioid Overdose Epidemic: It’s Not Just Opioids
Long-Term Recovery: The Essential Roles of Families and Addiction Treatment Providers
Holly Dye
MRC, Beyond Birth Program Director
University of Kentucky HealthCare
Holly Dye, MRC, is a nationally recognized expert on addiction and the impact on children. After 20 years of work with foster children, in-patient and out-patient drug treatment settings, Dye created a model program for medical and behavioral health interventions with families impacted by substance abuse that utilized telehealth networks, a basic online training program and a 16-hour training curriculum for professionals. She has authored numerous publications, many specific to substance use disorders and child development, and has developed programs for parents with addiction. She is the recipient of the 2012 Bluegrass Alliance for Women, Impact Award; 2011 Department of Homeland Security Service Award; 2008 Victim Impact Program Service Award; 2006 Champion for Children Award, presented by Prevent Child Abuse Kentucky; and the 2007 Recognition Award by the Federal Medical Center for work done for the Victim Impact Program. She was featured in the A&E Special A Question of Life or Meth, which received the Daytime Emmy Award for Outstanding Special, June 14, 2007. Dye currently works as the Program Manager of the Beyond Birth at University of Kentucky HealthCare and the University of Kentucky, College of Nursing Perinatal Research Center in Lexington, Kentucky.
Do the Next Right Thing: A Family-Centered and Multidisciplinary Approach to Substance Use Disorder Treatment among Perinatal Women
MRC, Beyond Birth Program Director
University of Kentucky HealthCare
Holly Dye, MRC, is a nationally recognized expert on addiction and the impact on children. After 20 years of work with foster children, in-patient and out-patient drug treatment settings, Dye created a model program for medical and behavioral health interventions with families impacted by substance abuse that utilized telehealth networks, a basic online training program and a 16-hour training curriculum for professionals. She has authored numerous publications, many specific to substance use disorders and child development, and has developed programs for parents with addiction. She is the recipient of the 2012 Bluegrass Alliance for Women, Impact Award; 2011 Department of Homeland Security Service Award; 2008 Victim Impact Program Service Award; 2006 Champion for Children Award, presented by Prevent Child Abuse Kentucky; and the 2007 Recognition Award by the Federal Medical Center for work done for the Victim Impact Program. She was featured in the A&E Special A Question of Life or Meth, which received the Daytime Emmy Award for Outstanding Special, June 14, 2007. Dye currently works as the Program Manager of the Beyond Birth at University of Kentucky HealthCare and the University of Kentucky, College of Nursing Perinatal Research Center in Lexington, Kentucky.
Do the Next Right Thing: A Family-Centered and Multidisciplinary Approach to Substance Use Disorder Treatment among Perinatal Women
John Eadie, MPA
Coordinator, Public Health and Prescription Drug Monitoring Program Project
National Emerging Threat Initiative, A National HIDTA Initiative
John Eadie is the Public Health & Prescription Drug Monitoring Program project coordinator for the National Emerging Threat Initiative of the National HIDTA Assistance Center. He previously served as director of the Prescription Drug Monitoring Program (PDMP) Center of Excellence at Brandeis University (2010-2015). For 44 years, Eadie has served in management, executive and consulting capacities in the field of public health. As director of the Division of Public Health Protection in the New York State Department of Health (1985-1995), he directed the state’s pharmaceutical diversion program, including the PDMP. He co-founded both the Alliance of States with Prescription Monitoring Programs and the National Association of State Controlled Substances Authorities, served as president for both organizations and held other posts. Since leaving New York state service in 2001, Eadie has served as a consultant on PDMPs, including serving as the administrative reviewer for the Massachusetts PDMP.
Stimulants and Opioids: An Emerging Drug Threat in the Midst of the Opioid Epidemic
Coordinator, Public Health and Prescription Drug Monitoring Program Project
National Emerging Threat Initiative, A National HIDTA Initiative
John Eadie is the Public Health & Prescription Drug Monitoring Program project coordinator for the National Emerging Threat Initiative of the National HIDTA Assistance Center. He previously served as director of the Prescription Drug Monitoring Program (PDMP) Center of Excellence at Brandeis University (2010-2015). For 44 years, Eadie has served in management, executive and consulting capacities in the field of public health. As director of the Division of Public Health Protection in the New York State Department of Health (1985-1995), he directed the state’s pharmaceutical diversion program, including the PDMP. He co-founded both the Alliance of States with Prescription Monitoring Programs and the National Association of State Controlled Substances Authorities, served as president for both organizations and held other posts. Since leaving New York state service in 2001, Eadie has served as a consultant on PDMPs, including serving as the administrative reviewer for the Massachusetts PDMP.
Stimulants and Opioids: An Emerging Drug Threat in the Midst of the Opioid Epidemic
Harry Earle
MA, Chief of Police
Gloucester Township (New Jersey) Police Department
Harry Earle, MA, is the Chief of Police of the Gloucester Township Police Department in Camden County, New Jersey. He has served with the department since 1988 and been Chief since 2010. Earle has implemented numerous community and problem-solving policing models with a focus on overall crime prevention through new programs targeting at-risk youth and early victimization identification. Earle holds a bachelor's degree in criminal justice, a master’s degree in human resource development, and is a graduate of the FBI National Academy. Earle is the President of the Camden County Chiefs of Police Association, and serves on numerous boards and committees including the Camden County College Police Academy Advisory Board, the New Jersey Council on Juvenile Justice System Improvement, and the New Jersey Human Trafficking Commission. Earle has lectured on the topics of police professionalism, bullying, peer mediation, violence prevention in schools, community policing, addiction and prevention of child sexual exploitation.
Changing Attitudes: Law Enforcement, Public Health and Naloxone
MA, Chief of Police
Gloucester Township (New Jersey) Police Department
Harry Earle, MA, is the Chief of Police of the Gloucester Township Police Department in Camden County, New Jersey. He has served with the department since 1988 and been Chief since 2010. Earle has implemented numerous community and problem-solving policing models with a focus on overall crime prevention through new programs targeting at-risk youth and early victimization identification. Earle holds a bachelor's degree in criminal justice, a master’s degree in human resource development, and is a graduate of the FBI National Academy. Earle is the President of the Camden County Chiefs of Police Association, and serves on numerous boards and committees including the Camden County College Police Academy Advisory Board, the New Jersey Council on Juvenile Justice System Improvement, and the New Jersey Human Trafficking Commission. Earle has lectured on the topics of police professionalism, bullying, peer mediation, violence prevention in schools, community policing, addiction and prevention of child sexual exploitation.
Changing Attitudes: Law Enforcement, Public Health and Naloxone
Paul Earley
MD, Georgia Professionals Health Program, Inc.
President-Elect, Federation of State Physician Health Programs
Dr. Paul Earley has been an addiction medicine physician for over 30 years. He specializes in the assessment, treatment and management of healthcare professionals with addictive disorders. He also works with patients already in recovery, providing long-term therapy. He is the author of two books and numerous articles on addiction and its treatment. He is a contributing author to the American Society of Addiction Medicine (ASAM) textbook, "The ASAM Principles of Addiction Medicine," and the ASAM criteria. His most recent book, "RecoveryMind Training," is an innovative and comprehensive process designed to reengineer addiction treatment. His work was featured in the documentary series on addiction entitled "Close to Home" by Bill Moyers. Earley is the Medical Director of the Georgia Professionals Health Program, Inc., the Physicians Health Program for the state of Georgia, and the President-elect of the Federation of State Physician Health Programs. He is the President-elect of ASAM. Earley is the recipient of the ASAM Annual Award in 2015.
Improving Addiction Outcomes: Lessons from the Physician Health Program Model
MD, Georgia Professionals Health Program, Inc.
President-Elect, Federation of State Physician Health Programs
Dr. Paul Earley has been an addiction medicine physician for over 30 years. He specializes in the assessment, treatment and management of healthcare professionals with addictive disorders. He also works with patients already in recovery, providing long-term therapy. He is the author of two books and numerous articles on addiction and its treatment. He is a contributing author to the American Society of Addiction Medicine (ASAM) textbook, "The ASAM Principles of Addiction Medicine," and the ASAM criteria. His most recent book, "RecoveryMind Training," is an innovative and comprehensive process designed to reengineer addiction treatment. His work was featured in the documentary series on addiction entitled "Close to Home" by Bill Moyers. Earley is the Medical Director of the Georgia Professionals Health Program, Inc., the Physicians Health Program for the state of Georgia, and the President-elect of the Federation of State Physician Health Programs. He is the President-elect of ASAM. Earley is the recipient of the ASAM Annual Award in 2015.
Improving Addiction Outcomes: Lessons from the Physician Health Program Model
Doug Edwards
Director
Institute for the Advancement of Behavioral Healthcare
Doug Edwards is Director of the Institute for the Advancement of Behavioral Healthcare, which produces the National Conference on Addiction Disorders, the National Rx Drug Abuse & Heroin Summit, the Summits for Clinical Excellence, and other conferences for behavioral healthcare professionals and allied stakeholders. He previously was the Editor-in-Chief and Publisher of both Addiction Professional and Behavioral Healthcare magazines. Edwards has been serving the mental health and addiction treatment community for more than 17 years. Noted for his behavioral healthcare market expertise, Edwards presents at conferences and moderates expert panel discussions around the country. He earned his master's degree in business administration from Franklin University and his bachelor's degree from The University of Akron.
Welcome and Opening Plenary Session
Director
Institute for the Advancement of Behavioral Healthcare
Doug Edwards is Director of the Institute for the Advancement of Behavioral Healthcare, which produces the National Conference on Addiction Disorders, the National Rx Drug Abuse & Heroin Summit, the Summits for Clinical Excellence, and other conferences for behavioral healthcare professionals and allied stakeholders. He previously was the Editor-in-Chief and Publisher of both Addiction Professional and Behavioral Healthcare magazines. Edwards has been serving the mental health and addiction treatment community for more than 17 years. Noted for his behavioral healthcare market expertise, Edwards presents at conferences and moderates expert panel discussions around the country. He earned his master's degree in business administration from Franklin University and his bachelor's degree from The University of Akron.
Welcome and Opening Plenary Session
Gary Enos
MS, Editor
Addiction Professional
Gary Enos has been editor of Addiction Professional since the publication’s inception in 2003. He has covered clinical, business and policy issues as an editor and reporter in the addiction and mental health fields since 1994. Enos also has moderated panels at numerous events for the Institute for the Advancement of Behavioral Healthcare, including the annual National Conference on Addiction Disorders (NCAD). Prior to his work in behavioral health, he was a reporter covering state and local government issues for Crain Communications’ City & State newspaper, and a government reporter at the Fort Lauderdale Sun-Sentinel. Enos is a graduate of Brown University and Northwestern University’s Medill School of Journalism.
MS, Editor
Addiction Professional
Gary Enos has been editor of Addiction Professional since the publication’s inception in 2003. He has covered clinical, business and policy issues as an editor and reporter in the addiction and mental health fields since 1994. Enos also has moderated panels at numerous events for the Institute for the Advancement of Behavioral Healthcare, including the annual National Conference on Addiction Disorders (NCAD). Prior to his work in behavioral health, he was a reporter covering state and local government issues for Crain Communications’ City & State newspaper, and a government reporter at the Fort Lauderdale Sun-Sentinel. Enos is a graduate of Brown University and Northwestern University’s Medill School of Journalism.
Jose' Esquibel
Director, Office of Community Engagement
Colorado Office of the Attorney General
Since 2013, José Esquibel has served as the Vice Chair of Prevention for the Colorado Statewide Substance Abuse Trend and Response Task Force, a legislatively mandated task force chaired by Attorney General Cynthia H. Coffman. His role includes active participation in a collaborative and comprehensive approach to addressing multiple issues related to Rx drug abuse through the Colorado Consortium for Prescription Drug Abuse Prevention. The consortium serves as the official Rx drug abuse prevention committee of the task force and is focused on implementing the goals of the Colorado Plan to Reduce Prescription Drug Abuse Prevention Plan related to public awareness, provider and prescriber education, the prescription drug monitoring program, and disposal of unused household medications. Esquibel's experience in substance abuse prevention includes work at the community level and within state government.
Colorado AmeriCorps Community Opioid Response Program
Director, Office of Community Engagement
Colorado Office of the Attorney General
Since 2013, José Esquibel has served as the Vice Chair of Prevention for the Colorado Statewide Substance Abuse Trend and Response Task Force, a legislatively mandated task force chaired by Attorney General Cynthia H. Coffman. His role includes active participation in a collaborative and comprehensive approach to addressing multiple issues related to Rx drug abuse through the Colorado Consortium for Prescription Drug Abuse Prevention. The consortium serves as the official Rx drug abuse prevention committee of the task force and is focused on implementing the goals of the Colorado Plan to Reduce Prescription Drug Abuse Prevention Plan related to public awareness, provider and prescriber education, the prescription drug monitoring program, and disposal of unused household medications. Esquibel's experience in substance abuse prevention includes work at the community level and within state government.
Colorado AmeriCorps Community Opioid Response Program
Greg Fabisiak
Environmental Integration Coordinator
Colorado Department of Public Health and Environment
Greg Fabisiak joined the Colorado Department of Public Health and Environment in 2009 following a 27-year career in water and wastewater utility management. As the department’s Environmental Integration Coordinator, he provides leadership in formulating and implementing approaches to address emerging environmental issues and those that fall outside of traditional, media-specific regulatory programs. This includes developing the department’s strategy to reduce impacts to public health and the environment from improperly disposed pharmaceuticals. In this role, Fabisiak manages the Colorado Household Medication Take-Back Program and works with a diverse group of stakeholders to expand and promote this program statewide, so that all residents have may access to safe and environmentally-sound options for medication disposal. Fabisiak also serves as co-chair of the Safe Disposal Work Group at the Colorado Consortium for Prescription Drug Abuse Prevention.
Safe Disposal in Colorado: A State-Led Approach
Environmental Integration Coordinator
Colorado Department of Public Health and Environment
Greg Fabisiak joined the Colorado Department of Public Health and Environment in 2009 following a 27-year career in water and wastewater utility management. As the department’s Environmental Integration Coordinator, he provides leadership in formulating and implementing approaches to address emerging environmental issues and those that fall outside of traditional, media-specific regulatory programs. This includes developing the department’s strategy to reduce impacts to public health and the environment from improperly disposed pharmaceuticals. In this role, Fabisiak manages the Colorado Household Medication Take-Back Program and works with a diverse group of stakeholders to expand and promote this program statewide, so that all residents have may access to safe and environmentally-sound options for medication disposal. Fabisiak also serves as co-chair of the Safe Disposal Work Group at the Colorado Consortium for Prescription Drug Abuse Prevention.
Safe Disposal in Colorado: A State-Led Approach
Laura Fanucchi
MD, MPH, Assistant Professor of Medicine
University of Kentucky
Laura Fanucchi, MD, MPH, is a general internist with additional board certification in addiction medicine. She obtained her medical degree from Emory University School of Medicine, completed internal medicine residency at New York Presbyterian Hospital Weill Cornell Medical College, and is currently Assistant Professor of Medicine at the University of Kentucky. Fanucchi’s clinical and research focus is on improving the care of hospitalized and medically complex patients with substance use disorders. She is currently providing treatment for opioid use disorder in HIV primary care at the University of Kentucky Bluegrass Care Clinic.
Do the Next Right Thing: A Family-Centered and Multidisciplinary Approach to Substance Use Disorder Treatment among Perinatal Women
MD, MPH, Assistant Professor of Medicine
University of Kentucky
Laura Fanucchi, MD, MPH, is a general internist with additional board certification in addiction medicine. She obtained her medical degree from Emory University School of Medicine, completed internal medicine residency at New York Presbyterian Hospital Weill Cornell Medical College, and is currently Assistant Professor of Medicine at the University of Kentucky. Fanucchi’s clinical and research focus is on improving the care of hospitalized and medically complex patients with substance use disorders. She is currently providing treatment for opioid use disorder in HIV primary care at the University of Kentucky Bluegrass Care Clinic.
Do the Next Right Thing: A Family-Centered and Multidisciplinary Approach to Substance Use Disorder Treatment among Perinatal Women
